Amit Berson

Amit Berson

Auto-generated profile, based on publicly available information

Amit Berson

Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Trends in Neurosciences
Verified
Journal Article
Closed access
ABAmit Berson
Amit Berson
RNRaffaella Nativio
Raffaella Nativio
SBShelley L. Berger
Shelley L. Berger
NBNancy M. Bonini
Nancy M. Bonini

5 March 2018 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
RNRaffaella Nativio
Raffaella Nativio
GDGreg Donahue
Greg Donahue
ABAmit Berson
Amit Berson
YLYemin Lan
Yemin Lan
AAAlexandre Amlie-Wolf
Alexandre Amlie-Wolf
SBShelley L. Berger
Shelley L. Berger
Aging is the strongest risk factor for Alzheimer’s disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD.

1 October 2015 in Genetics
Verified
Journal Article
Open access
PDF file
LMLeeanne McGurk
Leeanne McGurk
ABAmit Berson
Amit Berson
NBNancy M. Bonini
Nancy M. Bonini
With the increase in the ageing population, neurodegenerative disease is devastating to families and poses a huge burden on society. The brain and spinal cord are extraordinarily complex: they consist of a highly organized network of neuronal and support cells that communicate in a highly specialized manner. One approach to tackling problems of such complexity is to address the scientific questions in simpler, yet analogous, systems. The fruit fly, Drosophila melanogaster, has been proven tremendously valuable as a model organism, enabling many major discoveries in neuroscientific disease research. The plethora of genetic tools available in Drosophila allows for exquisite targeted manipulation of the genome. Due to its relatively short lifespan, complex questions of brain function can be addressed more rapidly than in other model organisms, such as the mouse. Here we discuss features of the fly as a model for human neurodegenerative disease. There are many distinct fly models for a range of neurodegenerative diseases; we focus on select studies from models of polyglutamine disease and amyotrophic lateral sclerosis that illustrate the type and range of insights that can be gleaned. In discussion of these models, we underscore strengths of the fly in providing understanding into mechanisms and pathways, as a foundation for translational and therapeutic research.

25 May 2012 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
ABAmit Berson
Amit Berson
SBShahar Barbash
Shahar Barbash
GSGalit Shaltiel
Galit Shaltiel
YGYael Goll
Yael Goll
GHGeula Hanin
Geula Hanin
HSHermona Soreq
Hermona Soreq
Genetic studies link inherited errors in RNA metabolism to familial neurodegenerative disease. Here, we report such errors and the underlying mechanism in sporadic Alzheimer9s disease (AD). AD entorhinal cortices presented globally impaired exon exclusions and selective loss of the hnRNP A/B splicing factors. Supporting functional relevance, hnRNP A/B knockdown induced alternative splicing impairments and dendrite loss in primary neurons, and memory and electrocorticographic impairments in mice. Transgenic mice with disease‐associated mutations in APP or Tau displayed no alterations in hnRNP A/B suggesting that its loss in AD is independent of Aβ and Tau toxicity. However, cholinergic excitation increased hnRNP A/B levels while in vivo neurotoxin‐mediated destruction of cholinergic neurons caused cortical AD‐like decrease in hnRNP A/B and recapitulated the alternative splicing pattern of AD patients. Our findings present cholinergic‐mediated hnRNP A/B loss and impaired RNA metabolism as important mechanisms involved in AD.

1 December 2017 in Current Biology
Verified
Journal Article
Closed access
ABAmit Berson
Amit Berson
ASAshley Sartoris
Ashley Sartoris
RNRaffaella Nativio
Raffaella Nativio
VDVivianna Van Deerlin
Vivianna Van Deerlin
JTJon B. Toledo
Jon B. Toledo
NBNancy M. Bonini
Nancy M. Bonini

3 December 2007 in Brain
Verified
Journal Article
Open access
PDF file
ABAmit Berson
Amit Berson
MKMarlen Knobloch
Marlen Knobloch
MHMor Hanan
Mor Hanan
SDSophia Diamant
Sophia Diamant
MSMichal Sharoni
Michal Sharoni
HSHermona Soreq
Hermona Soreq
Alzheimer's disease has long been known to involve cholinergic deficits, but the linkage between cholinergic gene expression and the Alzheimer's disease amyloid pathology has remained incompletely understood. One known link involves synaptic acetylcholinesterase (AChE-S), shown to accelerate amyloid fibrils formation. Here, we report that the ‘Readthrough’ AChE-R splice variant, which differs from AChE-S in its 26 C-terminal residues, inversely exerts neuroprotective effects from amyloid β (Aβ) induced toxicity. In vitro, highly purified AChE-R dose-dependently suppressed the formation of insoluble Aβ oligomers and fibrils and abolished Aβ toxicity to cultured cells, competing with the prevalent AChE-S protein which facilitates these processes. In vivo, double transgenic APPsw/AChE-R mice showed lower plaque burden, fewer reactive astrocytes and less dendritic damage than single APPsw mice, inverse to reported acceleration of these features in double APPsw/AChE-S mice. In hippocampi from Alzheimer's disease patients (n = 10), dentate gyrus neurons showed significantly elevated AChE-R mRNA and reduced AChE-S mRNA. However, immunoblot analyses revealed drastic reductions in the levels of intact AChE-R protein, suggesting that its selective loss in the Alzheimer's disease brain exacerbates the Aβ-induced damages and revealing a previously unforeseen linkage between cholinergic and amyloidogenic events.